Builds a polished Excel financial model for any company. Give it a public company ticker (data pulled automatically from Yahoo Finance and SEC EDGAR) or a private company spreadsheet, and it outputs a fully formatted .xlsx with a 3-statement model (Income Statement, Balance Sheet, Cash Flow) plus DCF valuation — 5 years historical, 5 years projected, WACC build-up, and a sensitivity table.
Turn local research hypotheses into traceable evidence. Validate daily CSVs, compare predeclared moving-average strategies with chronological holdouts, stress transaction costs, and independently audit results. Includes a Python standard-library lab, visual HTML reports and optional local Vibe-Trading helpers. Analysis and offline simulation only; no access to real user accounts.
Screens your watchlist for VCP/CANSLIM breakout setups, then backtests each candidate before presenting it — a graded shortlist, not a raw stock tip.
掃描你的價格資料、找出候選策略——而且對每一個講真話。它回測上百個經典組合、排成 leaderboard，然後做 hype 工具不敢做的事：照你試的個數幫最佳 Sharpe 打折（Deflated Sharpe）、檢查樣本外還剩多少、估過擬合機率——漂亮的曲線一律當成待驗證的假設、不是能交易的策略。睡前設好讓它整夜掃，掃越久對你越懷疑。自包含 HTML 報告（中／英）、跑在你自己的 CSV 上。
每天收盤後掃描全美約 5,700 檔股票,自動找出傳奇交易員 Qullamaggie 的三大型態——Episodic Pivot(事件跳空)、Breakout(強勢突破)、Parabolic Short(拋物過熱)。互動雙語儀表板、個股 setup 歷史、財報催化驗證、市場多空燈號、部位試算與方法論教學。型態篩選與教育用途,非投資建議。
Paste financial statement data and get a professional-grade diagnostic in minutes: Seeking-Alpha-style factor grades (A+ to F, sector-relative), a thesis-led variant view, earnings quality with accruals screening and a YoY profit bridge, 5-step DuPont ROE, cash conversion cycle, valuation multiples vs sector with a what's-priced-in check, graded risks, catalysts, analyst questions — plus a print-ready infographic one-page HTML report. Analysis only, never investment advice.
Professional multi-timeframe stock analysis with conviction scoring, market regime context, risk assessment, and buy/sell/hold signal. Just type a ticker — no setup needed.
A historical backtesting and validation-research protocol for algorithmic trading strategies: it treats your entry/exit/TP-SL/capital/leverage as fixed test inputs, stress-tests them with real costs and anti-overfit gates (plateau rule, walk-forward, random control, per-year robustness), and reports a research verdict (VALIDATION GATES PASSED / FAILED / INSUFFICIENT EVIDENCE). Analysis only: never deployment, sizing, leverage, or allocation advice.